F
Foghorn Therapeutics Inc. (FHTX)
NGM – Real Time Price. Currency in USD
4.24
-0.09 (-2.08%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
4.24
-0.09 (-2.08%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.92 | 6.05 | 10 | |
| Quick ratio | 2.92 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.19 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 19M | 34M | 23M | 31M | 28M |
| Gross Profit | 11M | 25M | 19M | 28M | 25M |
| Operating Income | -117M | -108M | -100M | -82M | -81M |
| Net Income | -109M | -98M | -87M | -74M | -75M |
| EBITDA | -109M | -99M | -97M | -79M | -78M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 0.49 | 10.36 | 4.5 |
| Next quarter | -4.73 | -0.8 | 1.0 |
| Current year | -16.88 | 11.36 | 4.0 |
| Next year | 45.68 | 13.48 | 9.0 |
| Weighted average score | 4.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -64.66 | 8.26 | 17.14 | -13.44 | 4.3 |
| Y/Y | -45.1 | -5.52 | 3.33 | -5.28 | 1.8 |
| 3y average | 26.85 | 11.94 | 22.83 | -43.97 | 7.0 |
| 5y average | 329.01 | -3.77 | 25.55 | 62.89 | 7.8 |
| Weighted average score | 5.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $88.9M significantly exceed its total debt $42.0M, ensuring strong financial flexibility
Total current assets $188.1M exceed Total current liabilities $64.4M, highlighting excellent liquidity
Debt-to-equity ratio (-0.5) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$25.3M limits the company's ability to reinvest or pay down debt